Otezla and Simponi drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Otezla (apremilast) and Simponi (golimumab). Common drug interactions include malaise among females and drug ineffective among males.
The phase IV clinical study analyzes what interactions people have when they take Otezla and Simponi. It is created by eHealthMe based on reports of 3,660 people who take the same drugs from the FDA, and is updated regularly.
What is Otezla?
Otezla has active ingredients of apremilast. It is often used in psoriatic arthritis. eHealthMe is studying from 146,254 Otezla users. Check the latest studies of Otezla.
What is Simponi?
Simponi has active ingredients of golimumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 86,328 Simponi users. Check the latest studies of Simponi.
3,660 people who take Otezla and Simponi together, and have interactions are studied.
What are the common drug interactions of Otezla and Simponi, by gender? *
What are the common drug interactions of Otezla and Simponi, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Otezla and Simponi?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Otezla and Simponi:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Otezla:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Simponi:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Otezla and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Simponi and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Azuma N, Matsui K, Hashimoto N, Yoshikawa T, Sano H, "Successful Switch to Golimumab for Eosinophilia and Skin Symptoms Related to Multiple Biologics in a Patient with Rheumatoid Arthritis", Internal Medicine, 2017 Jun .
- Azuma N, Matsui K, Hashimoto N, Yoshikawa T, Sano H, "Successful Switch to Golimumab for Eosinophilia and Skin Symptoms Related to Multiple Biologics in a Patient with Rheumatoid Arthritis", Internal Medicine, 2017 Jun .
How the study uses the data?
The study uses data from the FDA. It is based on apremilast and golimumab (the active ingredients of Otezla and Simponi, respectively), and Otezla and Simponi (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Basaglar cause Otitis? - now
- Drug interactions of Phenazopyridine Hcl and Lunesta - 3 seconds ago
- Could Miralax cause Protein Total Increased? - 5 seconds ago
- Drug interactions of Spectazole and Vicodin - 7 seconds ago
- Could Raxar cause Abdominal Pain Aggravated? - 10 seconds ago
- Could Metoprolol Succinate cause Abdominal Mass? - 11 seconds ago
- Could Eloxatin cause Pain? - 15 seconds ago
- Could Pamidronate Disodium cause Hyponatraemia Aggravated? - 19 seconds ago
- How effective is Acetaminophen for Migraine? - 32 seconds ago
- Could Lantus cause Suicidal Ideation? - 32 seconds ago